Nonprofit · EIN 20-4950952
EPILEPSY STUDY CONSORTIUM INC
Tax-exempt · RESTON, VA 20191
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $2,492,541 | $2,221,138 | $271,403 | $3,725,581 | $0 | $3,725,581 |
| December 31, 2023 | 990 | $3,371,798 | $1,701,465 | $1,670,333 | $3,454,178 | $0 | $3,454,178 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $512,456
- Program service revenue
- $1,919,904
- Investment income
- $60,181
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $119,000
- Compensation of officers, directors and key employees
- $422,558
- Other salaries and wages
- $385,442
- Salaries, compensation and benefits (total)
- $882,849
- Professional fundraising fees
- $0
- Accounting fees
- $35,000
- Occupancy
- $3,414
- Travel
- $49,704
- Program services (functional)
- $2,184,709
- Management and general (functional)
- $36,429
Balance sheet and other
- Total assets, start of year
- $3,454,178
- Total assets, end of year
- $3,725,581
- Total liabilities, end of year
- $0
- Net assets, end of year
- $3,725,581
- Gross receipts
- $2,492,541
- Employees
- 7
- Volunteers
- 11
- Year formed
- 2006
- State of legal domicile
- VA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| BREE DIVENTURA | CO-EXECUTIVE DIRECTOR Trustee or director, Officer | 40 | $233,530 | $7,006 |
| MERYL J LOZANO | CO-EXECUTIVE DIRECTOR Trustee or director, Officer | 40 | $150,417 | $0 |
| TRACY L DE VITO | EMPLOYEE Highest-paid employee | 40 | $110,004 | $0 |
| MICHAEL GELFAND MD | DIRECTOR Trustee or director | 1 | $22,152 | $0 |
| GREGORY KRAUSS MD | DIRECTOR Trustee or director | 1 | $4,875 | $0 |
| MICHAEL SPERLING MD | DIRECTOR Trustee or director | 1 | $4,228 | $0 |
| JAMES LINTOTT ESQ | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| JACQUELINE FRENCH MD | PRESIDENT Trustee or director, Officer | 5 | $0 | $0 |
| DENNIS DLUGOS MD | VICE PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| DANIEL FRIEDMAN MD | VICE PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| DAWN ELIASHIV MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PAVEL KLEIN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SUDHA KESSLER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT WECHSLER MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CLAUDE STERIADE MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
1 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| JENNIE MINNICK | EXECUTIVE COMMITTEE MEMBER Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 16 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| BREE DIVENTURA | CO-EXECUTIVE DIRECTOR Trustee or director, Officer | 40 | $194,484 | $5,835 |
| MERYL LOZANO | CO-EXECUTIVE DIRECTOR Trustee or director, Officer | 40 | $141,167 | $0 |
| TRACY L DE VITO | EMPLOYEE Highest-paid employee | 40 | $104,612 | $0 |
| MICHAEL GELFAND MD | DIRECTOR Trustee or director | 1 | $27,413 | $0 |
| HINA DAVE MD | DIRECTOR Trustee or director | 1 | $1,725 | $0 |
| MICHAEL SPERLING MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GREGORY KRAUSS MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN POLLARD MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PAVEL KLEIN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SUDHA KESSLER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARC DICHTER MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CLAUDE STERIADE MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES LINTOTT ESQ | TREASURER Officer | 1 | $0 | $0 |
| JACQUELINE FRENCH MD | PRESIDENT Officer | 5 | $0 | $0 |
| DENNIS DLUGOS MD | VICE PRESIDENT Officer | 1 | $0 | $0 |
| DANIEL FRIEDMAN MD | VICE PRESIDENT Officer | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 12030 SUNRISE VALLEY DR STE 450, RESTON, VA 20191-3400
- In care of
- % STERLING FOUNDATION MANAGEMENT LL
- Principal officer (990 for 2024)
- JAMES LINTOTT, 12030 SUNRISE VALLEY DRIVE 450, RESTON, VA 20191
- Signed the 990
- JAMES LINTOTT, TREASURER
- Phone
- (703) 437-9720
- Website
- WWW.EPILEPSYCONSORTIUM.ORG
- Return prepared by
- GORFINE SCHILLER & GARDYN PA
Mission
ACCELERATING THE DEVELOPMENT OF NEW THERAPIES IN EPILEPSY TO IMPROVE PATIENT CARE THROUGH RESEARCH.
Program accomplishments
- CONSULTING - MADE AVAILABLE VAST EPILEPSY EXPERTISE WHICH WAS UTILIZED FOR ADVISORY BOARDS AND INDEPENDENT CONSULTING ACTIVITY. PROVIDED STUDY DESIGN CONSULTATION ON A NUMBER OF PROTOCOLS. DEVELOPED AND IMPLEMENTED EDUCATIONAL TOOLS FOR USE IN CLINICAL TRIALS TO ENSURE ENROLLMENT OF APPROPRIATE SUBJECTS. CENTRAL REVIEW OF DOCUMENTATION TO CONFIRM ELIGIBILITY FOR PATIENTS IN CLINICAL TRIALS. DEVELOPED SEVERAL PROOF OF PRINCIPLE PROTOCOLS WHICH ARE AVAILABLE TO CLIENTS. IMPLEMENTED THE PREVIOUSLY DESIGNED PROOF OF PRINCIPLE STUDY TO ASSESS PHOTOSENSITIVE EPILEPSY INCLUDING SITE TRAINING.Expenses $1,432,788 · grants $119,000 · revenue $1,919,904
- HUMAN EPILEPSY PROJECT - CONTINUING TO ANALYZE DATA FROM HEP 1 & HEPS 2 STUDIES. OVERSEE AND COORDINATE THE FINANCIAL ASPECTS OF THE HEP3 STUDY. TESC MANAGES HEP3 STUDYS LIFE CYCLE FOR NYU, OVERSEES AND COORDINATES FINANCIAL ASPECTS OF THE STUDY AND THE PARTICIPATING SITES.Expenses $731,363
- TRIAL DESIGNS - PREPARE AND ORGANIZE MULTINATIONAL SYMPOSIUM ON EPILEPSY TRIAL DESIGN AND IMPLEMENTATION.Expenses $20,558
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-4950952
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2007
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G54)
- Assets (IRS master file)
- $3,725,581
- Income (IRS master file)
- $2,492,541
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $2,492,541 | $2,221,138 | $3,725,581 | XML |
| 990 | December 2023 | $3,371,798 | $1,701,465 | $3,454,178 | XML |
| 990 | December 2022 | $2,128,414 | $1,917,817 | $1,783,845 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-4950952).
Questions about EPILEPSY STUDY CONSORTIUM INC
- What is the EIN of EPILEPSY STUDY CONSORTIUM INC?
- The employer identification number (EIN) of EPILEPSY STUDY CONSORTIUM INC is 20-4950952.
- Is EPILEPSY STUDY CONSORTIUM INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
- Are donations to EPILEPSY STUDY CONSORTIUM INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does EPILEPSY STUDY CONSORTIUM INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of EPILEPSY STUDY CONSORTIUM INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did EPILEPSY STUDY CONSORTIUM INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of EPILEPSY STUDY CONSORTIUM INC?
- The 990 for the year ended December 31, 2024 names JAMES LINTOTT.
- Who are the officers and directors of EPILEPSY STUDY CONSORTIUM INC?
- The 990 for the year ended December 31, 2024 lists 16 people; 6 received compensation from the organization, the highest $233,530 (BREE DIVENTURA, CO-EXECUTIVE DIRECTOR).
- How much revenue does EPILEPSY STUDY CONSORTIUM INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $2,492,541, expenses of $2,221,138 and total assets of $3,725,581 at year end.
Other nonprofits in RESTON
- AMERICAN COLLEGE OF RADIOLOGY EIN 36-2261602 · last filed 990 for 2025
- SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING EIN 36-2496678 · last filed 990 for 2025
- SJOGRENS FOUNDATION INC EIN 11-2779073 · last filed 990 for 2025
- AMERICAN CONGRESS OF REHABILITATION MEDICINE EIN 36-2170784 · last filed 990 for 2024
- SOCIETY OF TOXICOLOGIC PATHOLOGY EIN 22-7134561 · last filed 990 for 2025
- MACKENZIES MISSION EIN 82-2590946 · last filed 990 for 2025
- AMERICAN ACADEMY OF OTOLARNGIC ALLERGY FOUNDATION INC EIN 22-2480270 · last filed 990 for 2024
- INTERNATIONAL UNION OF TOXICOLOGY INCORPORATED EIN 22-2532651 · last filed 990-EZ for 2025
All nonprofits in RESTON · Virginia · Voluntary health associations and medical disciplines